"Dimethyl Fumarate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A fumarate derivative that is used as a DERMATOLOGIC AGENT in the treatment of PSORIASIS and SKIN DISEASES. It also may be used as an IMMUNOSUPPRESSIVE AGENT in the treatment of MULTIPLE SCLEROSIS.
| Descriptor ID |
D000069462
|
| MeSH Number(s) |
D02.241.081.337.302.500
|
| Concept/Terms |
Dimethyl Fumarate- Dimethyl Fumarate
- Fumarate, Dimethyl
- 2-butenedioic acid, (2E)-, dimethyl ester
- Dimethylfumarate
BG 00012- BG 00012
- 00012, BG
- BG00012
- BG-00012
FAG 201- FAG 201
- 201, FAG
- FAG201
- FAG-201
BG 12 compound- BG 12 compound
- 12 compound, BG
- compound, BG 12
- BG12 compound
- compound, BG12
- BG-12 compound
|
Below are MeSH descriptors whose meaning is more general than "Dimethyl Fumarate".
Below are MeSH descriptors whose meaning is more specific than "Dimethyl Fumarate".
This graph shows the total number of publications written about "Dimethyl Fumarate" by people in this website by year, and whether "Dimethyl Fumarate" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2018 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
| 2021 | 0 | 2 | 2 |
| 2022 | 0 | 1 | 1 |
| 2023 | 0 | 1 | 1 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Dimethyl Fumarate" by people in Profiles.
-
Association of oral disease-modifying agents and their adherence trajectories with annual relapses in multiple sclerosis. Mult Scler Relat Disord. 2024 May; 85:105539.
-
Comparative adherence trajectories of oral disease-modifying agents in multiple sclerosis. Pharmacotherapy. 2023 06; 43(6):473-484.
-
FACTORS ASSOCIATED WITH SWITCHING FROM INJECTABLE TO ORAL DISEASE MODIFYING AGENTS AMONG PATIENTS WITH MULTIPLE SCLEROSIS. Mult Scler Relat Disord. 2022 Apr; 60:103703.
-
NRF2 promotes urothelial cell response to bacterial infection by regulating reactive oxygen species and RAB27B expression. Cell Rep. 2021 10 19; 37(3):109856.
-
The concurrence of multiple sclerosis and glioblastoma. Mult Scler Relat Disord. 2021 May; 50:102877.
-
Oral Dimethyl Fumarate Reduces Peripheral Neuropathic Pain in Rodents via NFE2L2 Antioxidant Signaling. Anesthesiology. 2020 02; 132(2):343-356.
-
Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity. Science. 2018 04 27; 360(6387):449-453.